Literature DB >> 8024023

Physiological increases in cortisol inhibit basal vasopressin release in conscious dogs.

P E Papanek1, H Raff.   

Abstract

Glucocorticoid deficiency leads to elevated plasma vasopressin (AVP), while chronic endogenous hypercortisolism may inhibit osmotically stimulated AVP, suggesting that glucocorticoids may be feedback inhibitors of AVP secretion. We evaluated the effect of physiological increases in cortisol (65 mg/day iv) for 7 days on basal AVP and oxytocin (OT) in five conscious, male dogs. Cortisol increased from 1.3 +/- 0.1 to 5.0 +/- 0.8 micrograms/dl during infusion. Basal plasma AVP significantly decreased from 3.5 +/- 0.2 to 2.6 +/- 0.3 pg/ml during cortisol infusion. Plasma OT, osmolality, and sodium did not change while arterial pressure decreased (from 107 +/- 3 to 102 +/- 2 mmHg) on days 4 and 6. Increases in cortisol led to a physiologically significant, nonosmotic decrease in AVP. The effect was specific to AVP and independent of changes in arterial pressure. Glucocorticoid administration significantly decreased basal AVP within 24 h, which is comparable to the negative feedback control of adrenocorticotropic hormone. The inverse relationship between cortisol and AVP may account for the nonosmotic change in AVP in patients with disorders of glucocorticoid secretion.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8024023     DOI: 10.1152/ajpregu.1994.266.6.R1744

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  7 in total

1.  A role for mineralocorticoid receptors in the physiology of the ovine fetus: effects on ACTH and lung liquid composition.

Authors:  Maureen Keller-Wood; Charles E Wood; Jarret McCartney; Nathan M Jesse; Dana Perrone
Journal:  Pediatr Res       Date:  2011-06       Impact factor: 3.756

2.  Cardiovascular and endocrine responses to acute hypoxaemia during and following dexamethasone infusion in the ovine fetus.

Authors:  Andrew J W Fletcher; David S Gardner; C Mark B Edwards; Abigail L Fowden; Dino A Giussani
Journal:  J Physiol       Date:  2003-03-28       Impact factor: 5.182

3.  Plasma carboxy-terminal provasopressin (copeptin): a novel marker of insulin resistance and metabolic syndrome.

Authors:  Umer Saleem; Mahyar Khaleghi; Nils G Morgenthaler; Andreas Bergmann; Joachim Struck; Thomas H Mosley; Iftikhar J Kullo
Journal:  J Clin Endocrinol Metab       Date:  2009-04-14       Impact factor: 5.958

4.  Carbenoxolone Disodium Treatment for Canine Pituitary-Dependent Hyperadrenocorticism.

Authors:  Takahiro Teshima; Hirotaka Matsumoto; Tomoko Okusa; Rion Uchiyama; Hidekazu Koyama
Journal:  PLoS One       Date:  2016-11-08       Impact factor: 3.240

5.  Be aware of the effects of glucocorticoids on SIADH: A case report.

Authors:  Huaqian Li; Lijun Huang; Ge Wu; Xianmei Chen; Qiaoan Zheng; Faming Su; Maoshan Liang; Xiaoming Chen
Journal:  Medicine (Baltimore)       Date:  2019-02       Impact factor: 1.817

6.  Severe hyponatremia as the presenting manifestation of primary empty sella syndrome.

Authors:  Kullaya Takkavatakarn; Aschariya Wipattanakitcharoen; Pisut Katavetin; Somchai Eiam-Ong
Journal:  Clin Case Rep       Date:  2022-02-03

7.  A case of extreme hyponatremia without neurologic symptoms.

Authors:  Na Zhou; Chang Yang
Journal:  Clin Case Rep       Date:  2019-08-20
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.